DelistingAug 4, 2026, 05:28 PM
VSEE Health to be Delisted from Nasdaq Capital Market
AI Summary
VSEE Health, Inc. received a notice from Nasdaq indicating its securities will be delisted from the Nasdaq Capital Market. This follows the company's failure to comply with the minimum bid price rule, specifically having a closing bid price of $0.10 or less for ten consecutive trading days. Trading of the company's common stock and warrants is scheduled to be suspended at the opening of business on August 6, 2026. The company is considering its options, including an appeal to the Nasdaq Hearings Panel, but there is no assurance of success or a stay of the trading suspension.
Key Highlights
- VSEE Health received initial Nasdaq non-compliance notice on September 24, 2025, for bid price below $1.00.
- Granted two 180-day compliance periods, extending until September 21, 2026.
- Received subsequent notice on July 30, 2026, for bid price below $0.10 for 10 consecutive days.
- Nasdaq determined to delist the company's securities from the Nasdaq Capital Market.
- Trading of common stock and warrants will be suspended at market open on August 6, 2026.
- Company may request a hearing with Nasdaq Hearings Panel by August 6, 2026, with a $20,000 fee.
- A timely appeal request will not stay the trading suspension of the company's securities.
Price Impact
More from VSEE